News

Brainstorm Cell Therapeutics plans to launch a Phase 3b trial to test NurOwn against a placebo in about 200 people with mild ...
Columnist Kristin Neva and her husband, Todd, marked the 15-year anniversary of his ALS diagnosis with a rare outing and ...
Living with ALS presents unique challenges. Columnist Dagmar Munn implements a mental shift that helps her ride the ups and downs.
High-dose dazucorilant patients who went into the open-label extension saw an 84% lower risk of death over those who didn't ...